GSK Committed To Patient Outcomes

Dr. Jonathan Pan, Vice President, GM of Malaysia, GSK

30-May-22 08:00

Pause
Embed

GSK will split into two new companies in 2022, they are GSK and Haleon. So what does this spin-off mean for Malaysia and the healthcare industry? Philip See speaks to Dr. Jonathan Pan, Vice President and GM of Malaysia and Brunei at GSK about their top-selling drugs, their role in the Covid-19 pandemic, and can Malaysia be a vaccine manufacturing hub?

Produced by: Moh Heng Ying

Presented by: Philip See

This and more than 60,000 other podcasts in your hand. Download the all new BFM mobile app.

Categories: Corporates, managing disease, medical advances

Tags: gsk,

Today’s Shows

11:00 AM

Best of Enterprise

(REPEAT) Hann Liew, Founder and CEO of Halogen Capital, joins BFM to review a volatile 2025 and outline the outlook for 2026.

12:00 PM

Popcorn Culture

(REPEAT) In this double bill episode, we review the newly concluded Season 1 of Apple TV's Pluribus, and discuss whether it has us excited for a second season of this philosophical sci-fi mystery.

1:00 PM

Cruise Control

(REPEAT) We kick off the first episode of this year with Daniel's thoughts on the iCaur V23, an EV that, according to him, is simply awesome.

2:00 PM

Matt-Splained

(REPEAT) In a world of constant iteration cycles and incremental upgrades, we take time to salute some of the big names and services that the tech world lost in 2026.

3:00 PM

Earth Matters

(REPEAT) Fireflies in Bukit Kiara signal ecosystem health under urban pressure. We explore why they matter, and how a new intiative called The Glow Campaign is driving collective action.

4:00 PM

Bar None

(REPEAT) We explore pickleball's rise in popularity and whether it's here to stay.

5:00 PM

BBC World Service

BFM presents the BBC World Service, which provides in-depth coverage of issues from around the world.

PROGRAMMES